WeVote
Log In

Bill

WeVote Research Nonpartisan
Bill Summary · SB 2230

Legislative bill overview

SB 2230 establishes or modifies lung cancer screening protocols and access in Hawaii. The bill has recently been introduced and referred to the Health and Human Services (HHS) and Consumer Protection and Commerce (CPN) committees for review. Specific provisions are not detailed in the available action history, but the focus is clearly on improving lung cancer detection and screening standards in the state.

Why is this important

Lung cancer remains one of Hawaii's leading causes of cancer-related deaths, and screening programs have been shown to reduce mortality in high-risk populations. Expanding or standardizing screening access could catch cancers earlier when treatment is more effective, potentially saving lives and reducing long-term healthcare costs. This is particularly relevant given Hawaii's aging population and historical smoking rates.

Potential points of contention

  • Cost and funding: Whether the state or insurance providers bear screening costs, and whether uninsured or underinsured residents have equitable access
  • Screening criteria: Debate over who qualifies (age, smoking history, risk factors) and whether criteria are appropriately targeted or overly broad
  • Healthcare infrastructure: Whether Hawaii's medical facilities have adequate capacity for increased screening volume and follow-up diagnostic procedures

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.